Revision as of 06:04, 4 October 2011 editThe chemistds (talk | contribs)Extended confirmed users5,761 edits added CSID, (Std)InChI & (Std)InChIKey← Previous edit | Revision as of 06:15, 4 October 2011 edit undoCheMoBot (talk | contribs)Bots141,565 edits Updating {{drugbox}} (no changed fields - added verified revid - updated 'ChemSpiderID_Ref', 'DrugBank_Ref', 'UNII_Ref', 'ChEMBL_Ref', 'ChEBI_Ref', 'KEGG_Ref', 'StdInChI_Ref', 'StdInChIKey_Ref', 'DrugBank_Ref', 'ChEBI_Ref') per [[WP:CHEMVALID|Chem/DrNext edit → | ||
Line 1: | Line 1: | ||
{{Drugbox | {{Drugbox | ||
| verifiedrevid = 453844015 | |||
| IUPAC_name = (±)-1-(3,4-dimethylphenyl)-2-(methylamino)propan-1-one | | IUPAC_name = (±)-1-(3,4-dimethylphenyl)-2-(methylamino)propan-1-one | ||
| image = 34DMMC_structure.png | | image = 34DMMC_structure.png | ||
Line 21: | Line 22: | ||
| ATC_suffix = | | ATC_suffix = | ||
| PubChem = 52988261 | | PubChem = 52988261 | ||
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} | |||
| |
| ChemSpiderID = 25630192 | ||
| InChI = 1/C12H17NO/c1-8-5-6-11(7-9(8)2)12(14)10(3)13-4/h5-7,10,13H,1-4H3 | | InChI = 1/C12H17NO/c1-8-5-6-11(7-9(8)2)12(14)10(3)13-4/h5-7,10,13H,1-4H3 | ||
| InChIKey = IBZRXTVDTGVBIS-UHFFFAOYAD | | InChIKey = IBZRXTVDTGVBIS-UHFFFAOYAD | ||
| StdInChI_Ref = {{stdinchicite|correct|chemspider}} | |||
| |
| StdInChI = 1S/C12H17NO/c1-8-5-6-11(7-9(8)2)12(14)10(3)13-4/h5-7,10,13H,1-4H3 | ||
⚫ | | |
||
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}} | |||
⚫ | | StdInChIKey = IBZRXTVDTGVBIS-UHFFFAOYSA-N | ||
<!--Chemical data--> | <!--Chemical data--> |
Revision as of 06:15, 4 October 2011
Pharmaceutical compoundClinical data | |
---|---|
ATC code |
|
Identifiers | |
IUPAC name
| |
PubChem CID | |
ChemSpider | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C12H17NO |
Molar mass | 191.269 g/mol g·mol |
3D model (JSmol) | |
SMILES
| |
InChI
| |
(verify) |
3,4-Dimethylmethcathinone (3,4-DMMC) is a stimulant drug first reported in 2010 as a designer drug analogue of mephedrone, apparently produced in response to the banning of mephedrone, following its widespread abuse in many countries in Europe and around the world.
See also
References
This drug article relating to the nervous system is a stub. You can help Misplaced Pages by expanding it. |